Cemented Engage Partial Knee for Osteoarthritis, Knee

Phase-Based Progress Estimates
JIS Research Institute, New Albany, OH
Osteoarthritis, Knee
Engage Partial Knee - Device
All Sexes
What conditions do you have?

Study Summary

This trial is looking at whether a new type of knee replacement is as good as the existing one. The Cemented Engage Partial Knee is used to treat patients with osteoarthritis of the knee. There will be no placebo group in this trial.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

0 Primary · 4 Secondary · Reporting Duration: 2 Year

2 Year
Implant Survivorship
Month 24
Pain Score
Range of Motion
Month 12

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Cemented Engage Partial Knee
1 of 2
Cementless Engage Partial Knee
1 of 2
Active Control

108 Total Participants · 2 Treatment Groups

Primary Treatment: Cemented Engage Partial Knee · No Placebo Group · N/A

Cemented Engage Partial Knee
ActiveComparator Group · 1 Intervention: Engage Partial Knee · Intervention Types: Device
Cementless Engage Partial Knee
ActiveComparator Group · 1 Intervention: Engage Partial Knee · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 year
Closest Location: JIS Research Institute · New Albany, OH
Photo of ohio 1Photo of ohio 2Photo of ohio 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Osteoarthritis, Knee
0 CompletedClinical Trials

Who is running the clinical trial?

JIS Research InstituteLead Sponsor
Smith & Nephew, Inc.Industry Sponsor
156 Previous Clinical Trials
21,718 Total Patients Enrolled
11 Trials studying Osteoarthritis, Knee
1,446 Patients Enrolled for Osteoarthritis, Knee
David A Crawford, MDPrincipal InvestigatorJIS Research Institute

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a pre-operative Knee Society Assessment Score of <70.
You are male or female and at least 21 years of age at the time of surgery.
You have cartilage loss in the medial compartment of the knee.
You have pain or improved function in your knee.
You have a fixed flexion deformity of < 15°.
You are willing and able to return for follow-up evaluations.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.